down arrow

Zenlabs Ethica

  • Market Cap: Micro Cap
  • Industry: Diversified Commercial Services
  • ISIN: INE546F01013
  • NSEID:
  • BSEID: 530697
INR
22.55
-0.27 (-1.18%)
BSENSE

Dec 15

BSE+NSE Vol: 62.76 k

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Zenlabs Ethica Ltd stock-summary
stock-summary
Zenlabs Ethica Ltd
Micro Cap
Diversified Commercial Services
Zenlabs Ethica Limited (Formerly known Neelkanth Technologies Limited) was incorporated in 1993. The Company is one of the top 10 pharmaceutical contract marketing and trading companies in India that markets and distribute a wide range of branded drugs including Gastrointestinal disorders, Anti-Diabetics, Anti-Hypertensive Drugs, Anti-Infective, Soaps & Anti-Bacterial Drugs, Nutraceuticals, etc., It boasts of a comprehensive global network.
Company Coordinates stock-summary
Company Details
Plot No 194-195 3rd Flr Pha-II, Industrial Area Ram Darbar Chandigarh Chandigarh ( U T ) : 160002
stock-summary
Tel: 91-172-4651105/3920738
stock-summary
http://www.zenlabsindia.com; www.zenlabsethica.com
stock-summary
queries@zenlabsethica.com
Registrar Details
Bigshare Services Pvt Ltd , E-2 , Ansa Industrial Estate, Saki Vihar Road, Saki Naka, Andheri (E), Mumbai
stock-summary Capital Structure
Capital Structure stock-summary
Present Equity Capital
INR 6.51 Cr
Number of Shares
65.1 Cr
Face Value
INR 10.0
Date
Number
of Shares(Cr)
Equity
Capital (Rs Cr)
Shares Added
Face Value (Rs)
Reason
11-Oct-2018
65.1
6.51
310001
10
Bonus
02-Jan-2016
62
6.20
2582514
10
Allotment of Equity To Others
02-Jan-2016
62
6.20
2582514
10
Allotment of Equity To Others
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Preet Remedies Limited (26.58%)

Highest Public shareholder

Hitesh Popatlal Oswal (6.79%)

Individual Investors Holdings

38.35%

stock-summary Board of Directorsstock-summary
stock-summary
Management
Designation
Remuneration
Sanjeev Kumar
Managing Director & CEO
49.8 lacs
Him Jyoti
Director
0
Ashok Kumar Gupta
Independent Director
0
Sanjay Dhir
Whole Time Director & CFO
37.2 lacs
Anurag Malhotra
Independent Director
0
Kuldeep Singh
Director
0
HITESH POPATLAL OSWAL
Executive Director
0
Akshay Saxena
Company Sec. & Compli. Officer
0
stock-recommendationRaw Materials
Raw Materials Dashboard stock-summary
Raw Materials
Amount(Rs Cr)
% of RM Cost
 
Icon
No Data Available
stock-recommendation Finished Goods
Finished Goods Dashboard stock-summary
Finished Goods
Amount(Rs Cr)
% of Sales Turnover
Pharma Products - Traded
71.84
100.00%
 
100
Pharma Products - Traded
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
12 Cr
(Quarterly Results - Sep 2025)
Net Profit:
0 Cr
stock-summary
Industry

Diversified Commercial Services

stock-summary
Market cap

INR 16 Cr (Micro Cap)

stock-summary
P/E

59.00

stock-summary
Industry P/E

23

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.93

stock-summary
Return on Equity

2.37%

stock-summary
Price to Book

1.41

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."